nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0851	0.103	CbGbCtD
Nifedipine—ABCC3—Methotrexate—ankylosing spondylitis	0.0751	0.0909	CbGbCtD
Nifedipine—CYP2A6—Prednisolone—ankylosing spondylitis	0.0704	0.0852	CbGbCtD
Nifedipine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0426	0.0516	CbGbCtD
Nifedipine—ABCC2—Dexamethasone—ankylosing spondylitis	0.0425	0.0514	CbGbCtD
Nifedipine—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0415	0.0502	CbGbCtD
Nifedipine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0366	0.0443	CbGbCtD
Nifedipine—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0354	0.0429	CbGbCtD
Nifedipine—ABCC2—Methotrexate—ankylosing spondylitis	0.0341	0.0413	CbGbCtD
Nifedipine—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0284	0.0343	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0284	0.0343	CbGbCtD
Nifedipine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0274	0.0331	CbGbCtD
Nifedipine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.027	0.0327	CbGbCtD
Nifedipine—ABCB1—Betamethasone—ankylosing spondylitis	0.0238	0.0288	CbGbCtD
Nifedipine—ABCB1—Prednisolone—ankylosing spondylitis	0.0235	0.0284	CbGbCtD
Nifedipine—ABCB1—Prednisone—ankylosing spondylitis	0.0222	0.0268	CbGbCtD
Nifedipine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0219	0.0265	CbGbCtD
Nifedipine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0213	0.0257	CbGbCtD
Nifedipine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0205	0.0248	CbGbCtD
Nifedipine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0166	0.0201	CbGbCtD
Nifedipine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0143	0.0173	CbGbCtD
Nifedipine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0143	0.0173	CbGbCtD
Nifedipine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0141	0.017	CbGbCtD
Nifedipine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0138	0.0168	CbGbCtD
Nifedipine—CYP3A4—Prednisone—ankylosing spondylitis	0.0133	0.0161	CbGbCtD
Nifedipine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.013	0.0158	CbGbCtD
Nifedipine—ABCB1—Methotrexate—ankylosing spondylitis	0.0111	0.0135	CbGbCtD
Nifedipine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00829	0.01	CbGbCtD
Nifedipine—CALM3—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.000587	0.0769	CbGpPWpGaD
Nifedipine—CALM1—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.000567	0.0744	CbGpPWpGaD
Nifedipine—CALM2—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.000567	0.0744	CbGpPWpGaD
Nifedipine—CALM3—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.000385	0.0505	CbGpPWpGaD
Nifedipine—CALM1—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.000373	0.0488	CbGpPWpGaD
Nifedipine—CALM2—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.000373	0.0488	CbGpPWpGaD
Nifedipine—CALM3—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.000372	0.0487	CbGpPWpGaD
Nifedipine—CALM1—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.00036	0.0471	CbGpPWpGaD
Nifedipine—CALM2—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.00036	0.0471	CbGpPWpGaD
Nifedipine—Syncope—Betamethasone—ankylosing spondylitis	0.000238	0.00143	CcSEcCtD
Nifedipine—Syncope—Dexamethasone—ankylosing spondylitis	0.000238	0.00143	CcSEcCtD
Nifedipine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000237	0.00143	CcSEcCtD
Nifedipine—Sweating—Methotrexate—ankylosing spondylitis	0.000237	0.00143	CcSEcCtD
Nifedipine—Haematuria—Methotrexate—ankylosing spondylitis	0.000236	0.00142	CcSEcCtD
Nifedipine—Shock—Triamcinolone—ankylosing spondylitis	0.000235	0.00141	CcSEcCtD
Nifedipine—Insomnia—Prednisolone—ankylosing spondylitis	0.000235	0.00141	CcSEcCtD
Nifedipine—Alopecia—Prednisone—ankylosing spondylitis	0.000234	0.00141	CcSEcCtD
Nifedipine—Shock—Methylprednisolone—ankylosing spondylitis	0.000234	0.00141	CcSEcCtD
Nifedipine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000234	0.00141	CcSEcCtD
Nifedipine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000233	0.00141	CcSEcCtD
Nifedipine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000233	0.0014	CcSEcCtD
Nifedipine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000233	0.0014	CcSEcCtD
Nifedipine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000233	0.0014	CcSEcCtD
Nifedipine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000233	0.0014	CcSEcCtD
Nifedipine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000233	0.0014	CcSEcCtD
Nifedipine—Mental disorder—Prednisone—ankylosing spondylitis	0.000232	0.0014	CcSEcCtD
Nifedipine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000232	0.0014	CcSEcCtD
Nifedipine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000231	0.00139	CcSEcCtD
Nifedipine—Erythema—Prednisone—ankylosing spondylitis	0.000231	0.00139	CcSEcCtD
Nifedipine—Malnutrition—Prednisone—ankylosing spondylitis	0.000231	0.00139	CcSEcCtD
Nifedipine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000231	0.00139	CcSEcCtD
Nifedipine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000231	0.00139	CcSEcCtD
Nifedipine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00023	0.00139	CcSEcCtD
Nifedipine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000226	0.00136	CcSEcCtD
Nifedipine—Myalgia—Betamethasone—ankylosing spondylitis	0.000226	0.00136	CcSEcCtD
Nifedipine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000225	0.00135	CcSEcCtD
Nifedipine—Anxiety—Betamethasone—ankylosing spondylitis	0.000225	0.00135	CcSEcCtD
Nifedipine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000223	0.00134	CcSEcCtD
Nifedipine—Discomfort—Betamethasone—ankylosing spondylitis	0.000223	0.00134	CcSEcCtD
Nifedipine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000223	0.00134	CcSEcCtD
Nifedipine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000222	0.00134	CcSEcCtD
Nifedipine—Pain—Prednisolone—ankylosing spondylitis	0.000222	0.00134	CcSEcCtD
Nifedipine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000222	0.00134	CcSEcCtD
Nifedipine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000222	0.00134	CcSEcCtD
Nifedipine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00022	0.00133	CcSEcCtD
Nifedipine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000219	0.00132	CcSEcCtD
Nifedipine—Vision blurred—Prednisone—ankylosing spondylitis	0.000218	0.00131	CcSEcCtD
Nifedipine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000217	0.00131	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000217	0.00131	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000217	0.00131	CcSEcCtD
Nifedipine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000216	0.0013	CcSEcCtD
Nifedipine—Oedema—Dexamethasone—ankylosing spondylitis	0.000216	0.0013	CcSEcCtD
Nifedipine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000216	0.0013	CcSEcCtD
Nifedipine—Oedema—Betamethasone—ankylosing spondylitis	0.000216	0.0013	CcSEcCtD
Nifedipine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000216	0.0013	CcSEcCtD
Nifedipine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000215	0.0013	CcSEcCtD
Nifedipine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000214	0.00129	CcSEcCtD
Nifedipine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000214	0.00129	CcSEcCtD
Nifedipine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000214	0.00129	CcSEcCtD
Nifedipine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000214	0.00129	CcSEcCtD
Nifedipine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000214	0.00129	CcSEcCtD
Nifedipine—Anaemia—Prednisone—ankylosing spondylitis	0.000214	0.00129	CcSEcCtD
Nifedipine—Shock—Betamethasone—ankylosing spondylitis	0.000213	0.00128	CcSEcCtD
Nifedipine—Shock—Dexamethasone—ankylosing spondylitis	0.000213	0.00128	CcSEcCtD
Nifedipine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000213	0.00128	CcSEcCtD
Nifedipine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000212	0.00128	CcSEcCtD
Nifedipine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000212	0.00128	CcSEcCtD
Nifedipine—Agitation—Prednisone—ankylosing spondylitis	0.000212	0.00128	CcSEcCtD
Nifedipine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000212	0.00128	CcSEcCtD
Nifedipine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000212	0.00128	CcSEcCtD
Nifedipine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000211	0.00127	CcSEcCtD
Nifedipine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000211	0.00127	CcSEcCtD
Nifedipine—Angioedema—Prednisone—ankylosing spondylitis	0.000211	0.00127	CcSEcCtD
Nifedipine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00021	0.00126	CcSEcCtD
Nifedipine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00021	0.00126	CcSEcCtD
Nifedipine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00021	0.00126	CcSEcCtD
Nifedipine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000209	0.00126	CcSEcCtD
Nifedipine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000209	0.00126	CcSEcCtD
Nifedipine—Malaise—Prednisone—ankylosing spondylitis	0.000208	0.00125	CcSEcCtD
Nifedipine—Vertigo—Prednisone—ankylosing spondylitis	0.000208	0.00125	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000207	0.00125	CcSEcCtD
Nifedipine—Syncope—Prednisone—ankylosing spondylitis	0.000207	0.00125	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000207	0.00124	CcSEcCtD
Nifedipine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000206	0.00124	CcSEcCtD
Nifedipine—Anorexia—Betamethasone—ankylosing spondylitis	0.000206	0.00124	CcSEcCtD
Nifedipine—Urticaria—Prednisolone—ankylosing spondylitis	0.000206	0.00124	CcSEcCtD
Nifedipine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000206	0.00124	CcSEcCtD
Nifedipine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000206	0.00124	CcSEcCtD
Nifedipine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000205	0.00124	CcSEcCtD
Nifedipine—Pain—Triamcinolone—ankylosing spondylitis	0.000204	0.00123	CcSEcCtD
Nifedipine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000203	0.00122	CcSEcCtD
Nifedipine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000202	0.00122	CcSEcCtD
Nifedipine—Hypotension—Betamethasone—ankylosing spondylitis	0.000202	0.00122	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000201	0.00121	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.0002	0.00121	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.0002	0.0012	CcSEcCtD
Nifedipine—Chills—Methotrexate—ankylosing spondylitis	0.000199	0.0012	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000197	0.00119	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000197	0.00119	CcSEcCtD
Nifedipine—Myalgia—Prednisone—ankylosing spondylitis	0.000197	0.00118	CcSEcCtD
Nifedipine—Arthralgia—Prednisone—ankylosing spondylitis	0.000197	0.00118	CcSEcCtD
Nifedipine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000197	0.00118	CcSEcCtD
Nifedipine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000196	0.00118	CcSEcCtD
Nifedipine—Anxiety—Prednisone—ankylosing spondylitis	0.000196	0.00118	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—ankylosing spondylitis	0.000196	0.00118	CcSEcCtD
Nifedipine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000196	0.00118	CcSEcCtD
Nifedipine—Insomnia—Betamethasone—ankylosing spondylitis	0.000196	0.00118	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000195	0.00118	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000195	0.00117	CcSEcCtD
Nifedipine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000194	0.00117	CcSEcCtD
Nifedipine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000194	0.00117	CcSEcCtD
Nifedipine—Discomfort—Prednisone—ankylosing spondylitis	0.000194	0.00117	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000194	0.00117	CcSEcCtD
Nifedipine—Erythema—Methotrexate—ankylosing spondylitis	0.000193	0.00116	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000193	0.00116	CcSEcCtD
Nifedipine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000191	0.00115	CcSEcCtD
Nifedipine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000191	0.00115	CcSEcCtD
Nifedipine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000191	0.00115	CcSEcCtD
Nifedipine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00019	0.00114	CcSEcCtD
Nifedipine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000189	0.00114	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000189	0.00114	CcSEcCtD
Nifedipine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000189	0.00114	CcSEcCtD
Nifedipine—Oedema—Prednisone—ankylosing spondylitis	0.000189	0.00114	CcSEcCtD
Nifedipine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000189	0.00114	CcSEcCtD
Nifedipine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000188	0.00113	CcSEcCtD
Nifedipine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000188	0.00113	CcSEcCtD
Nifedipine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000188	0.00113	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000187	0.00113	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000187	0.00113	CcSEcCtD
Nifedipine—Back pain—Methotrexate—ankylosing spondylitis	0.000187	0.00112	CcSEcCtD
Nifedipine—Fatigue—Betamethasone—ankylosing spondylitis	0.000187	0.00112	CcSEcCtD
Nifedipine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000187	0.00112	CcSEcCtD
Nifedipine—Shock—Prednisone—ankylosing spondylitis	0.000185	0.00112	CcSEcCtD
Nifedipine—Pain—Dexamethasone—ankylosing spondylitis	0.000185	0.00111	CcSEcCtD
Nifedipine—Pain—Betamethasone—ankylosing spondylitis	0.000185	0.00111	CcSEcCtD
Nifedipine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000185	0.00111	CcSEcCtD
Nifedipine—Tachycardia—Prednisone—ankylosing spondylitis	0.000184	0.00111	CcSEcCtD
Nifedipine—Skin disorder—Prednisone—ankylosing spondylitis	0.000183	0.0011	CcSEcCtD
Nifedipine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000182	0.0011	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000182	0.0011	CcSEcCtD
Nifedipine—Anorexia—Prednisone—ankylosing spondylitis	0.00018	0.00108	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000179	0.00108	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—ankylosing spondylitis	0.000178	0.00107	CcSEcCtD
Nifedipine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000178	0.00107	CcSEcCtD
Nifedipine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000178	0.00107	CcSEcCtD
Nifedipine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000177	0.00107	CcSEcCtD
Nifedipine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000177	0.00107	CcSEcCtD
Nifedipine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000176	0.00106	CcSEcCtD
Nifedipine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000175	0.00106	CcSEcCtD
Nifedipine—Malaise—Methotrexate—ankylosing spondylitis	0.000174	0.00105	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—ankylosing spondylitis	0.000173	0.00104	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000173	0.00104	CcSEcCtD
Nifedipine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000172	0.00104	CcSEcCtD
Nifedipine—Urticaria—Betamethasone—ankylosing spondylitis	0.000172	0.00104	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000172	0.00103	CcSEcCtD
Nifedipine—Dizziness—Prednisolone—ankylosing spondylitis	0.000172	0.00103	CcSEcCtD
Nifedipine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000171	0.00103	CcSEcCtD
Nifedipine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000171	0.00103	CcSEcCtD
Nifedipine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000171	0.00103	CcSEcCtD
Nifedipine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000171	0.00103	CcSEcCtD
Nifedipine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000171	0.00103	CcSEcCtD
Nifedipine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000171	0.00103	CcSEcCtD
Nifedipine—Insomnia—Prednisone—ankylosing spondylitis	0.000171	0.00103	CcSEcCtD
Nifedipine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000169	0.00102	CcSEcCtD
Nifedipine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000169	0.00102	CcSEcCtD
Nifedipine—Cough—Methotrexate—ankylosing spondylitis	0.000168	0.00101	CcSEcCtD
Nifedipine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000168	0.00101	CcSEcCtD
Nifedipine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000166	0.000999	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—ankylosing spondylitis	0.000164	0.00099	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—ankylosing spondylitis	0.000164	0.00099	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000164	0.00099	CcSEcCtD
Nifedipine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000164	0.000987	CcSEcCtD
Nifedipine—Rash—Prednisolone—ankylosing spondylitis	0.000164	0.000985	CcSEcCtD
Nifedipine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000163	0.000984	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000163	0.000983	CcSEcCtD
Nifedipine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000163	0.000981	CcSEcCtD
Nifedipine—Fatigue—Prednisone—ankylosing spondylitis	0.000163	0.000979	CcSEcCtD
Nifedipine—Headache—Prednisolone—ankylosing spondylitis	0.000163	0.000979	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—ankylosing spondylitis	0.000162	0.000978	CcSEcCtD
Nifedipine—Constipation—Prednisone—ankylosing spondylitis	0.000161	0.000971	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—ankylosing spondylitis	0.000159	0.000956	CcSEcCtD
Nifedipine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000158	0.00095	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000158	0.000949	CcSEcCtD
Nifedipine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000157	0.000948	CcSEcCtD
Nifedipine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000155	0.000935	CcSEcCtD
Nifedipine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000155	0.000935	CcSEcCtD
Nifedipine—Asthenia—Betamethasone—ankylosing spondylitis	0.000155	0.000935	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000155	0.00093	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000154	0.000929	CcSEcCtD
Nifedipine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000154	0.000928	CcSEcCtD
Nifedipine—Nausea—Prednisolone—ankylosing spondylitis	0.000154	0.000928	CcSEcCtD
Nifedipine—Pruritus—Betamethasone—ankylosing spondylitis	0.000153	0.000922	CcSEcCtD
Nifedipine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000153	0.000922	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000153	0.000921	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000152	0.000917	CcSEcCtD
Nifedipine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000152	0.000913	CcSEcCtD
Nifedipine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000151	0.000911	CcSEcCtD
Nifedipine—Rash—Triamcinolone—ankylosing spondylitis	0.00015	0.000906	CcSEcCtD
Nifedipine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00015	0.000905	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—ankylosing spondylitis	0.00015	0.000904	CcSEcCtD
Nifedipine—Rash—Methylprednisolone—ankylosing spondylitis	0.00015	0.000904	CcSEcCtD
Nifedipine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00015	0.000903	CcSEcCtD
Nifedipine—Urticaria—Prednisone—ankylosing spondylitis	0.00015	0.000902	CcSEcCtD
Nifedipine—Headache—Triamcinolone—ankylosing spondylitis	0.000149	0.0009	CcSEcCtD
Nifedipine—Headache—Methylprednisolone—ankylosing spondylitis	0.000149	0.000898	CcSEcCtD
Nifedipine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000149	0.000897	CcSEcCtD
Nifedipine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000149	0.000897	CcSEcCtD
Nifedipine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000148	0.000892	CcSEcCtD
Nifedipine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000148	0.000892	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—ankylosing spondylitis	0.000147	0.000886	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000144	0.000864	CcSEcCtD
Nifedipine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000143	0.000862	CcSEcCtD
Nifedipine—Dizziness—Betamethasone—ankylosing spondylitis	0.000143	0.000862	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—ankylosing spondylitis	0.000143	0.000858	CcSEcCtD
Nifedipine—Nausea—Triamcinolone—ankylosing spondylitis	0.000142	0.000853	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000141	0.000852	CcSEcCtD
Nifedipine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000141	0.000851	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00014	0.000846	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—ankylosing spondylitis	0.00014	0.000843	CcSEcCtD
Nifedipine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000139	0.000836	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000139	0.000835	CcSEcCtD
Nifedipine—Vomiting—Betamethasone—ankylosing spondylitis	0.000138	0.000829	CcSEcCtD
Nifedipine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000138	0.000829	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000137	0.000825	CcSEcCtD
Nifedipine—Rash—Dexamethasone—ankylosing spondylitis	0.000137	0.000822	CcSEcCtD
Nifedipine—Rash—Betamethasone—ankylosing spondylitis	0.000137	0.000822	CcSEcCtD
Nifedipine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000136	0.000821	CcSEcCtD
Nifedipine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000136	0.000821	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000136	0.000819	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—ankylosing spondylitis	0.000136	0.000818	CcSEcCtD
Nifedipine—Headache—Betamethasone—ankylosing spondylitis	0.000136	0.000816	CcSEcCtD
Nifedipine—Headache—Dexamethasone—ankylosing spondylitis	0.000136	0.000816	CcSEcCtD
Nifedipine—Asthenia—Prednisone—ankylosing spondylitis	0.000135	0.000814	CcSEcCtD
Nifedipine—Pain—Methotrexate—ankylosing spondylitis	0.000135	0.000811	CcSEcCtD
Nifedipine—Pruritus—Prednisone—ankylosing spondylitis	0.000133	0.000803	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00013	0.000782	CcSEcCtD
Nifedipine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000129	0.000777	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000129	0.000776	CcSEcCtD
Nifedipine—Nausea—Betamethasone—ankylosing spondylitis	0.000129	0.000774	CcSEcCtD
Nifedipine—Nausea—Dexamethasone—ankylosing spondylitis	0.000129	0.000774	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—ankylosing spondylitis	0.000125	0.000754	CcSEcCtD
Nifedipine—Dizziness—Prednisone—ankylosing spondylitis	0.000125	0.000751	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000125	0.00075	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000125	0.00075	CcSEcCtD
Nifedipine—Vomiting—Prednisone—ankylosing spondylitis	0.00012	0.000722	CcSEcCtD
Nifedipine—Rash—Prednisone—ankylosing spondylitis	0.000119	0.000716	CcSEcCtD
Nifedipine—Dermatitis—Prednisone—ankylosing spondylitis	0.000119	0.000715	CcSEcCtD
Nifedipine—Headache—Prednisone—ankylosing spondylitis	0.000118	0.000711	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000116	0.000699	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—ankylosing spondylitis	0.000113	0.000681	CcSEcCtD
Nifedipine—Nausea—Prednisone—ankylosing spondylitis	0.000112	0.000674	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—ankylosing spondylitis	0.000111	0.000671	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000108	0.000649	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—ankylosing spondylitis	0.000104	0.000627	CcSEcCtD
Nifedipine—CACNA1H—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.0001	0.0131	CbGpPWpGaD
Nifedipine—Vomiting—Methotrexate—ankylosing spondylitis	0.0001	0.000603	CcSEcCtD
Nifedipine—Rash—Methotrexate—ankylosing spondylitis	9.93e-05	0.000598	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—ankylosing spondylitis	9.93e-05	0.000598	CcSEcCtD
Nifedipine—Headache—Methotrexate—ankylosing spondylitis	9.87e-05	0.000594	CcSEcCtD
Nifedipine—Nausea—Methotrexate—ankylosing spondylitis	9.36e-05	0.000563	CcSEcCtD
Nifedipine—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	9.02e-05	0.0118	CbGpPWpGaD
Nifedipine—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	8.73e-05	0.0114	CbGpPWpGaD
Nifedipine—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	8.73e-05	0.0114	CbGpPWpGaD
Nifedipine—CALM2—Endochondral Ossification—RUNX3—ankylosing spondylitis	8.69e-05	0.0114	CbGpPWpGaD
Nifedipine—CALM1—Endochondral Ossification—RUNX3—ankylosing spondylitis	8.69e-05	0.0114	CbGpPWpGaD
Nifedipine—CALM3—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	8.35e-05	0.011	CbGpPWpGaD
Nifedipine—CALM1—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	8.08e-05	0.0106	CbGpPWpGaD
Nifedipine—CALM2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	8.08e-05	0.0106	CbGpPWpGaD
Nifedipine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	7.5e-05	0.00982	CbGpPWpGaD
Nifedipine—ABCC3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	7.28e-05	0.00954	CbGpPWpGaD
Nifedipine—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.77e-05	0.00756	CbGpPWpGaD
Nifedipine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	5.4e-05	0.00708	CbGpPWpGaD
Nifedipine—CALM3—BCR signaling pathway—CD79A—ankylosing spondylitis	5.24e-05	0.00687	CbGpPWpGaD
Nifedipine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	5.23e-05	0.00685	CbGpPWpGaD
Nifedipine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	5.23e-05	0.00685	CbGpPWpGaD
Nifedipine—CALM2—BCR signaling pathway—CD79A—ankylosing spondylitis	5.07e-05	0.00665	CbGpPWpGaD
Nifedipine—CALM1—BCR signaling pathway—CD79A—ankylosing spondylitis	5.07e-05	0.00665	CbGpPWpGaD
Nifedipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	4.78e-05	0.00626	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	4.57e-05	0.00599	CbGpPWpGaD
Nifedipine—CACNA1S—Alzheimers Disease—TNF—ankylosing spondylitis	4.54e-05	0.00595	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	4.18e-05	0.00548	CbGpPWpGaD
Nifedipine—CALM3—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	3.97e-05	0.0052	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	3.88e-05	0.00509	CbGpPWpGaD
Nifedipine—CALM2—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	3.84e-05	0.00503	CbGpPWpGaD
Nifedipine—CALM1—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	3.84e-05	0.00503	CbGpPWpGaD
Nifedipine—CALM3—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	3.81e-05	0.005	CbGpPWpGaD
Nifedipine—CALM1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	3.69e-05	0.00484	CbGpPWpGaD
Nifedipine—CALM2—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	3.69e-05	0.00484	CbGpPWpGaD
Nifedipine—CACNA1D—Alzheimers Disease—TNF—ankylosing spondylitis	3.68e-05	0.00483	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	3.58e-05	0.00469	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	3.46e-05	0.00453	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	3.46e-05	0.00453	CbGpPWpGaD
Nifedipine—CACNA1C—Alzheimers Disease—TNF—ankylosing spondylitis	3.24e-05	0.00424	CbGpPWpGaD
Nifedipine—CALM3—DAP12 interactions—HLA-C—ankylosing spondylitis	3.16e-05	0.00414	CbGpPWpGaD
Nifedipine—CALM3—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	3.16e-05	0.00414	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	3.06e-05	0.00401	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	3.06e-05	0.00401	CbGpPWpGaD
Nifedipine—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	3.05e-05	0.004	CbGpPWpGaD
Nifedipine—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	3.05e-05	0.004	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	2.86e-05	0.00374	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	2.84e-05	0.00372	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	2.84e-05	0.00372	CbGpPWpGaD
Nifedipine—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	2.71e-05	0.00356	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	2.7e-05	0.00354	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	2.5e-05	0.00328	CbGpPWpGaD
Nifedipine—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	2.23e-05	0.00292	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	2.17e-05	0.00284	CbGpPWpGaD
Nifedipine—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	2.16e-05	0.00283	CbGpPWpGaD
Nifedipine—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	2.16e-05	0.00283	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	2.1e-05	0.00275	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	2.1e-05	0.00275	CbGpPWpGaD
Nifedipine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	2.09e-05	0.00273	CbGpPWpGaD
Nifedipine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	2.09e-05	0.00273	CbGpPWpGaD
Nifedipine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	2.06e-05	0.0027	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	2.05e-05	0.00269	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—B3GNT2—ankylosing spondylitis	2.04e-05	0.00268	CbGpPWpGaD
Nifedipine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	1.99e-05	0.00261	CbGpPWpGaD
Nifedipine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	1.99e-05	0.00261	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	1.99e-05	0.0026	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	1.99e-05	0.0026	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	1.96e-05	0.00256	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—B3GNT2—ankylosing spondylitis	1.93e-05	0.00254	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	1.89e-05	0.00248	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	1.89e-05	0.00248	CbGpPWpGaD
Nifedipine—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	1.87e-05	0.00245	CbGpPWpGaD
Nifedipine—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	1.84e-05	0.00242	CbGpPWpGaD
Nifedipine—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	1.84e-05	0.00242	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	1.81e-05	0.00237	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	1.81e-05	0.00237	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—B3GNT2—ankylosing spondylitis	1.7e-05	0.00223	CbGpPWpGaD
Nifedipine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	1.65e-05	0.00216	CbGpPWpGaD
Nifedipine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	1.59e-05	0.00209	CbGpPWpGaD
Nifedipine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	1.59e-05	0.00209	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—B3GNT2—ankylosing spondylitis	1.52e-05	0.002	CbGpPWpGaD
Nifedipine—CALM3—Disease—ANTXR2—ankylosing spondylitis	1.52e-05	0.00199	CbGpPWpGaD
Nifedipine—CALM1—Disease—ANTXR2—ankylosing spondylitis	1.47e-05	0.00192	CbGpPWpGaD
Nifedipine—CALM2—Disease—ANTXR2—ankylosing spondylitis	1.47e-05	0.00192	CbGpPWpGaD
Nifedipine—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	1.43e-05	0.00187	CbGpPWpGaD
Nifedipine—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	1.38e-05	0.00181	CbGpPWpGaD
Nifedipine—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	1.38e-05	0.00181	CbGpPWpGaD
Nifedipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	1.33e-05	0.00174	CbGpPWpGaD
Nifedipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	1.33e-05	0.00174	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL1R2—ankylosing spondylitis	1.31e-05	0.00172	CbGpPWpGaD
Nifedipine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	1.31e-05	0.00172	CbGpPWpGaD
Nifedipine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	1.31e-05	0.00172	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL1R2—ankylosing spondylitis	1.27e-05	0.00167	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL1R2—ankylosing spondylitis	1.27e-05	0.00167	CbGpPWpGaD
Nifedipine—CALM3—Immune System—ERAP1—ankylosing spondylitis	1.25e-05	0.00163	CbGpPWpGaD
Nifedipine—CACNA1H—Developmental Biology—TNF—ankylosing spondylitis	1.23e-05	0.00162	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	1.23e-05	0.00161	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ERAP1—ankylosing spondylitis	1.2e-05	0.00158	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ERAP1—ankylosing spondylitis	1.2e-05	0.00158	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	1.19e-05	0.00156	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	1.19e-05	0.00156	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	1.18e-05	0.00155	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	1.14e-05	0.0015	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	1.14e-05	0.0015	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CARD9—ankylosing spondylitis	1.14e-05	0.00149	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CARD9—ankylosing spondylitis	1.1e-05	0.00144	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CARD9—ankylosing spondylitis	1.1e-05	0.00144	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	1.08e-05	0.00142	CbGpPWpGaD
Nifedipine—CACNA1S—Developmental Biology—TNF—ankylosing spondylitis	1.05e-05	0.00137	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	1.04e-05	0.00136	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—B3GNT2—ankylosing spondylitis	9.54e-06	0.00125	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	9e-06	0.00118	CbGpPWpGaD
Nifedipine—CACNB2—Developmental Biology—TNF—ankylosing spondylitis	8.97e-06	0.00118	CbGpPWpGaD
Nifedipine—CALM3—Disease—B3GNT2—ankylosing spondylitis	8.94e-06	0.00117	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	8.7e-06	0.00114	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	8.7e-06	0.00114	CbGpPWpGaD
Nifedipine—CALM2—Disease—B3GNT2—ankylosing spondylitis	8.65e-06	0.00113	CbGpPWpGaD
Nifedipine—CALM1—Disease—B3GNT2—ankylosing spondylitis	8.65e-06	0.00113	CbGpPWpGaD
Nifedipine—CACNA1D—Developmental Biology—TNF—ankylosing spondylitis	8.5e-06	0.00111	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	7.7e-06	0.00101	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	7.54e-06	0.000988	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	7.52e-06	0.000986	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	7.49e-06	0.000982	CbGpPWpGaD
Nifedipine—CACNA1C—Developmental Biology—TNF—ankylosing spondylitis	7.47e-06	0.000979	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.33e-06	0.000961	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.27e-06	0.000953	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	7.26e-06	0.000952	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	7.25e-06	0.00095	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	7.25e-06	0.00095	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-C—ankylosing spondylitis	7.15e-06	0.000938	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	7.11e-06	0.000932	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.09e-06	0.00093	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.09e-06	0.00093	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.03e-06	0.000922	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.03e-06	0.000922	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	7.03e-06	0.000921	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	7.03e-06	0.000921	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.98e-06	0.000914	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-C—ankylosing spondylitis	6.92e-06	0.000907	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-C—ankylosing spondylitis	6.92e-06	0.000907	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.75e-06	0.000884	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.75e-06	0.000884	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	6.52e-06	0.000854	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.46e-06	0.000847	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—CRP—ankylosing spondylitis	6.42e-06	0.000842	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.25e-06	0.000819	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.25e-06	0.000819	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL1RN—ankylosing spondylitis	6.21e-06	0.000815	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—CRP—ankylosing spondylitis	6.21e-06	0.000814	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—CRP—ankylosing spondylitis	6.21e-06	0.000814	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	6.16e-06	0.000807	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL1RN—ankylosing spondylitis	6.01e-06	0.000788	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL1RN—ankylosing spondylitis	6.01e-06	0.000788	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	5.95e-06	0.00078	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	5.95e-06	0.00078	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	5.68e-06	0.000744	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD79A—ankylosing spondylitis	5.46e-06	0.000715	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	5.35e-06	0.000701	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	5.33e-06	0.000699	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	5.3e-06	0.000695	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD79A—ankylosing spondylitis	5.28e-06	0.000692	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD79A—ankylosing spondylitis	5.28e-06	0.000692	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	5.18e-06	0.000679	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	5.01e-06	0.000656	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.01e-06	0.000656	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—B3GNT2—ankylosing spondylitis	4.53e-06	0.000594	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL1A—ankylosing spondylitis	4.47e-06	0.000586	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD40LG—ankylosing spondylitis	4.45e-06	0.000583	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL1A—ankylosing spondylitis	4.33e-06	0.000567	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL1A—ankylosing spondylitis	4.33e-06	0.000567	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD40LG—ankylosing spondylitis	4.3e-06	0.000564	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD40LG—ankylosing spondylitis	4.3e-06	0.000564	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	4.3e-06	0.000563	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-B—ankylosing spondylitis	4.23e-06	0.000555	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	4.16e-06	0.000545	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.16e-06	0.000545	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-B—ankylosing spondylitis	4.09e-06	0.000536	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-B—ankylosing spondylitis	4.09e-06	0.000536	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HLA-A—ankylosing spondylitis	3.92e-06	0.000514	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HLA-A—ankylosing spondylitis	3.79e-06	0.000497	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HLA-A—ankylosing spondylitis	3.79e-06	0.000497	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CRP—ankylosing spondylitis	3.74e-06	0.00049	CbGpPWpGaD
Nifedipine—CALM3—Disease—HLA-A—ankylosing spondylitis	3.62e-06	0.000474	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CRP—ankylosing spondylitis	3.62e-06	0.000474	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CRP—ankylosing spondylitis	3.62e-06	0.000474	CbGpPWpGaD
Nifedipine—CALM3—Immune System—TLR4—ankylosing spondylitis	3.59e-06	0.00047	CbGpPWpGaD
Nifedipine—CALM1—Disease—HLA-A—ankylosing spondylitis	3.5e-06	0.000459	CbGpPWpGaD
Nifedipine—CALM2—Disease—HLA-A—ankylosing spondylitis	3.5e-06	0.000459	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	3.5e-06	0.000458	CbGpPWpGaD
Nifedipine—CALM2—Immune System—TLR4—ankylosing spondylitis	3.47e-06	0.000455	CbGpPWpGaD
Nifedipine—CALM1—Immune System—TLR4—ankylosing spondylitis	3.47e-06	0.000455	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	3.06e-06	0.000401	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	2.96e-06	0.000388	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	2.96e-06	0.000388	CbGpPWpGaD
